| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 6.03e-07 | 46 | 71 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | protein domain specific binding | SHANK1 FZD8 EVL ATN1 WIPF1 INPPL1 PKD2 ADGRB1 STRN4 IRS2 SRCIN1 POU5F1B AP4M1 CRK | 2.03e-06 | 875 | 71 | 14 | GO:0019904 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.54e-05 | 188 | 71 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.56e-04 | 143 | 71 | 5 | GO:0017124 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 COL4A2 MAP2K4 ATN1 COL19A1 STRN4 SMARCA4 SMARCC2 IRS2 SPEN BAG6 CUX1 CRK ZNF541 | 2.57e-04 | 1356 | 71 | 14 | GO:0060090 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.86e-04 | 46 | 71 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 9.38e-04 | 54 | 71 | 3 | GO:0030159 | |
| GeneOntologyMolecularFunction | profilin binding | 9.48e-04 | 13 | 71 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 9.48e-04 | 13 | 71 | 2 | GO:0001162 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SHANK1 CACNA1A EVL VAX1 EPHA6 ADGRB1 DNM3 SMARCA4 AUTS2 SRCIN1 NKX6-1 PEAK3 PTCH1 CUX1 CDH15 NOTCH3 CRK ARAP1 | 6.14e-08 | 1194 | 70 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | SHANK1 CACNA1A EVL VAX1 IRX5 EPHA6 INPPL1 ADGRB1 DNM3 AUTS2 DCLK2 SRCIN1 NKX6-1 PTCH1 TNXB SF3A2 CUX1 NOTCH3 CRK | 2.52e-07 | 1463 | 70 | 19 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | SHANK1 CACNA1A EVL VAX1 EPHA6 INPPL1 ADGRB1 DNM3 AUTS2 SRCIN1 NKX6-1 PTCH1 TNXB SF3A2 CUX1 NOTCH3 CRK | 9.72e-07 | 1285 | 70 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SHANK1 CACNA1A EVL VAX1 EPHA6 ADGRB1 DNM3 AUTS2 SRCIN1 NKX6-1 PTCH1 CUX1 NOTCH3 | 1.19e-06 | 748 | 70 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SHANK1 CACNA1A EVL VAX1 EPHA6 ADGRB1 DNM3 AUTS2 SRCIN1 NKX6-1 PTCH1 CUX1 NOTCH3 | 2.57e-06 | 802 | 70 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SHANK1 CACNA1A EVL VAX1 EPHA6 ADGRB1 DNM3 AUTS2 SRCIN1 NKX6-1 PTCH1 CUX1 NOTCH3 | 3.24e-06 | 819 | 70 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SHANK1 CACNA1A EVL VAX1 EPHA6 ADGRB1 DNM3 AUTS2 SRCIN1 NKX6-1 PTCH1 CUX1 NOTCH3 | 3.56e-06 | 826 | 70 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | brain development | CACNA1A VAX1 SMARCA4 DUOX2 IRS2 DCLK2 PTCH1 RTN1 BAG6 CIC NOTCH3 CRK | 2.90e-05 | 859 | 70 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | central nervous system development | CACNA1A VAX1 ATN1 SMARCA4 DUOX2 IRS2 DCLK2 NKX6-1 PTCH1 RTN1 BAG6 CIC NOTCH3 CRK | 4.14e-05 | 1197 | 70 | 14 | GO:0007417 |
| GeneOntologyBiologicalProcess | head development | CACNA1A VAX1 SMARCA4 DUOX2 IRS2 DCLK2 PTCH1 RTN1 BAG6 CIC NOTCH3 CRK | 5.58e-05 | 919 | 70 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | SHANK1 EVL WIPF1 INPPL1 ADGRB1 AUTS2 SRCIN1 PEAK3 TNXB CRK ARAP1 | 7.72e-05 | 803 | 70 | 11 | GO:0030036 |
| GeneOntologyBiologicalProcess | axonogenesis | 1.21e-04 | 566 | 70 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | reflex | 1.57e-04 | 31 | 70 | 3 | GO:0060004 | |
| GeneOntologyBiologicalProcess | rhythmic synaptic transmission | 1.69e-04 | 6 | 70 | 2 | GO:0060024 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | VAX1 ATN1 SMARCA4 ETV5 SMARCC2 POU5F1B NKX6-1 PTCH1 SPEN CIC CUX1 NOTCH3 | 2.02e-04 | 1053 | 70 | 12 | GO:0000122 |
| GeneOntologyBiologicalProcess | actin filament-based process | SHANK1 EVL WIPF1 INPPL1 ADGRB1 AUTS2 SRCIN1 PEAK3 TNXB CRK ARAP1 | 2.36e-04 | 912 | 70 | 11 | GO:0030029 |
| GeneOntologyBiologicalProcess | axon development | 3.10e-04 | 642 | 70 | 9 | GO:0061564 | |
| GeneOntologyCellularComponent | collagen trimer | 1.23e-05 | 88 | 71 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.69e-04 | 6 | 71 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.14e-04 | 8 | 71 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 3.14e-04 | 8 | 71 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 3.14e-04 | 8 | 71 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | bBAF complex | 5.03e-04 | 10 | 71 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | dendrite | SHANK1 CACNA1A MAP2K4 EPHA6 ADGRB1 STRN4 DNM3 SRCIN1 PTCH1 RTN1 | 6.15e-04 | 858 | 71 | 10 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | SHANK1 CACNA1A MAP2K4 EPHA6 ADGRB1 STRN4 DNM3 SRCIN1 PTCH1 RTN1 | 6.26e-04 | 860 | 71 | 10 | GO:0097447 |
| GeneOntologyCellularComponent | npBAF complex | 1.01e-03 | 14 | 71 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | RSC-type complex | 1.16e-03 | 15 | 71 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | nBAF complex | 1.32e-03 | 16 | 71 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | cell leading edge | 1.52e-03 | 500 | 71 | 7 | GO:0031252 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.12e-03 | 530 | 71 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.29e-03 | 21 | 71 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 3.14e-03 | 86 | 71 | 3 | GO:0001673 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 3.37e-03 | 576 | 71 | 7 | GO:0015629 | |
| Domain | Collagen | 1.78e-05 | 85 | 71 | 5 | IPR008160 | |
| Domain | Collagen | 1.78e-05 | 85 | 71 | 5 | PF01391 | |
| Domain | Homeodomain-like | 3.68e-05 | 332 | 71 | 8 | IPR009057 | |
| Domain | Homeobox_CS | 7.53e-05 | 186 | 71 | 6 | IPR017970 | |
| Domain | - | 9.89e-05 | 283 | 71 | 7 | 1.10.10.60 | |
| Domain | SAM_1 | 1.30e-04 | 68 | 71 | 4 | PF00536 | |
| Domain | C4 | 2.12e-04 | 6 | 71 | 2 | SM00111 | |
| Domain | - | 2.12e-04 | 6 | 71 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.12e-04 | 6 | 71 | 2 | IPR001442 | |
| Domain | C4 | 2.12e-04 | 6 | 71 | 2 | PF01413 | |
| Domain | NC1_IV | 2.12e-04 | 6 | 71 | 2 | PS51403 | |
| Domain | Homeobox | 2.63e-04 | 234 | 71 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.76e-04 | 236 | 71 | 6 | PS00027 | |
| Domain | HOX | 2.82e-04 | 237 | 71 | 6 | SM00389 | |
| Domain | HOMEOBOX_2 | 2.95e-04 | 239 | 71 | 6 | PS50071 | |
| Domain | Homeobox_dom | 2.95e-04 | 239 | 71 | 6 | IPR001356 | |
| Domain | SAM | 3.51e-04 | 88 | 71 | 4 | SM00454 | |
| Domain | SAM_DOMAIN | 4.70e-04 | 95 | 71 | 4 | PS50105 | |
| Domain | SAM | 5.09e-04 | 97 | 71 | 4 | IPR001660 | |
| Domain | - | 7.11e-04 | 106 | 71 | 4 | 1.10.150.50 | |
| Domain | SAM/pointed | 1.03e-03 | 117 | 71 | 4 | IPR013761 | |
| Domain | TSPN | 3.42e-03 | 23 | 71 | 2 | SM00210 | |
| Domain | tRNA-bd_arm | 3.73e-03 | 24 | 71 | 2 | IPR010978 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.04e-06 | 44 | 59 | 5 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 8.55e-06 | 67 | 59 | 5 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.50e-05 | 41 | 59 | 4 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.62e-05 | 90 | 59 | 5 | M631 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.21e-04 | 61 | 59 | 4 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.46e-04 | 64 | 59 | 4 | M26953 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.84e-04 | 76 | 59 | 4 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.84e-04 | 76 | 59 | 4 | MM14573 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 2.88e-04 | 31 | 59 | 3 | M39522 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.80e-04 | 34 | 59 | 3 | MM15531 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.89e-04 | 37 | 59 | 3 | M27797 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 5.56e-04 | 161 | 59 | 5 | M39770 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 7.53e-04 | 261 | 59 | 6 | MM15676 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.58e-04 | 10 | 59 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.58e-04 | 10 | 59 | 2 | MM1560 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 9.24e-04 | 11 | 59 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 9.24e-04 | 11 | 59 | 2 | M26913 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.11e-03 | 12 | 59 | 2 | MM1526 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 1.11e-03 | 12 | 59 | 2 | M22006 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.19e-03 | 50 | 59 | 3 | MM14796 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.30e-03 | 13 | 59 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.30e-03 | 13 | 59 | 2 | M12950 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.41e-03 | 53 | 59 | 3 | MM14566 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.52e-03 | 14 | 59 | 2 | MM1458 | |
| Pathway | PID_TCR_JNK_PATHWAY | 1.52e-03 | 14 | 59 | 2 | M190 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.52e-03 | 14 | 59 | 2 | M6487 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.54e-03 | 300 | 59 | 6 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.74e-03 | 57 | 59 | 3 | MM14713 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.75e-03 | 15 | 59 | 2 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.75e-03 | 15 | 59 | 2 | MM14922 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 1.75e-03 | 15 | 59 | 2 | MM14536 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.82e-03 | 58 | 59 | 3 | M2049 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EVL INTS5 ATN1 BRPF1 NAF1 SMARCA4 SMARCC2 IRS2 SPEN MN1 BAG6 CIC | 5.22e-08 | 774 | 71 | 12 | 15302935 |
| Pubmed | Evf2 lncRNA/BRG1/DLX1 interactions reveal RNA-dependent inhibition of chromatin remodeling. | 2.84e-07 | 7 | 71 | 3 | 26138476 | |
| Pubmed | 7.43e-07 | 153 | 71 | 6 | 25037231 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EVL EPHA6 MORN1 CACNA2D2 PKD2 AUTS2 RPRD2 DCLK2 SRCIN1 ZNF839 CUX1 CDH15 NOTCH3 ARAP1 | 1.60e-06 | 1489 | 71 | 14 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.76e-06 | 430 | 71 | 8 | 35044719 | |
| Pubmed | SHANK1 CACNA1A EVL MAP2K4 GLS ADGRB1 STRN4 BSDC1 SMARCC2 DCLK2 SRCIN1 RTN1 | 3.10e-06 | 1139 | 71 | 12 | 36417873 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25169943 | ||
| Pubmed | Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. | 4.11e-06 | 2 | 71 | 2 | 16474392 | |
| Pubmed | Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML. | 4.11e-06 | 2 | 71 | 2 | 33974912 | |
| Pubmed | PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization. | 4.11e-06 | 2 | 71 | 2 | 31311869 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 16928863 | ||
| Pubmed | 7.72e-06 | 19 | 71 | 3 | 22698544 | ||
| Pubmed | 7.72e-06 | 19 | 71 | 3 | 15689378 | ||
| Pubmed | An epigenetic circuit controls neurogenic programs during neocortex development. | 9.06e-06 | 20 | 71 | 3 | 35020876 | |
| Pubmed | Msx1 and Msx2 in limb mesenchyme modulate digit number and identity. | 9.06e-06 | 20 | 71 | 3 | 21465616 | |
| Pubmed | 9.06e-06 | 20 | 71 | 3 | 34220450 | ||
| Pubmed | FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds. | 1.06e-05 | 21 | 71 | 3 | 19386269 | |
| Pubmed | Broad-minded links cell cycle-related kinase to cilia assembly and hedgehog signal transduction. | 1.22e-05 | 22 | 71 | 3 | 20159594 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8621590 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 28287392 | ||
| Pubmed | Molecular architecture of CAG repeats in human disease related transcripts. | 1.23e-05 | 3 | 71 | 2 | 15223312 | |
| Pubmed | 1.40e-05 | 23 | 71 | 3 | 38828908 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | INTS5 MORN1 INPPL1 STRN4 IRS2 ABCD1 PTCH1 ZNF839 SPEN CIC ARAP1 | 1.42e-05 | 1105 | 71 | 11 | 35748872 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.64e-05 | 154 | 71 | 5 | 16055720 | |
| Pubmed | 1.82e-05 | 25 | 71 | 3 | 28288114 | ||
| Pubmed | 1.86e-05 | 268 | 71 | 6 | 33640491 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 9729467 | ||
| Pubmed | BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. | 2.46e-05 | 4 | 71 | 2 | 29894688 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 30810242 | ||
| Pubmed | Brg1 is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts. | 2.46e-05 | 4 | 71 | 2 | 20485553 | |
| Pubmed | Whole-exome sequencing of Finnish patients with vascular cognitive impairment. | 2.46e-05 | 4 | 71 | 2 | 33268848 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 17878164 | ||
| Pubmed | The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. | 2.46e-05 | 4 | 71 | 2 | 15150092 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 2.50e-05 | 583 | 71 | 8 | 29844126 | |
| Pubmed | Chromatin regulation by BAF170 controls cerebral cortical size and thickness. | 2.57e-05 | 28 | 71 | 3 | 23643363 | |
| Pubmed | 2.59e-05 | 83 | 71 | 4 | 28794006 | ||
| Pubmed | 2.87e-05 | 29 | 71 | 3 | 36800290 | ||
| Pubmed | 2.87e-05 | 29 | 71 | 3 | 26959361 | ||
| Pubmed | Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex. | 2.87e-05 | 29 | 71 | 3 | 20615956 | |
| Pubmed | Suppression of epithelial differentiation by Foxi3 is essential for molar crown patterning. | 3.18e-05 | 30 | 71 | 3 | 26450968 | |
| Pubmed | 3.37e-05 | 608 | 71 | 8 | 16713569 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 12244326 | ||
| Pubmed | Vax1 Plays an Indirect Role in the Etiology of Murine Cleft Palate. | 4.09e-05 | 5 | 71 | 2 | 28771384 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 18086889 | ||
| Pubmed | A small modulatory dsRNA specifies the fate of adult neural stem cells. | 4.09e-05 | 5 | 71 | 2 | 15035981 | |
| Pubmed | p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. | 4.09e-05 | 5 | 71 | 2 | 9584200 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 28855737 | ||
| Pubmed | 4.23e-05 | 94 | 71 | 4 | 16325481 | ||
| Pubmed | 5.85e-05 | 329 | 71 | 6 | 17474147 | ||
| Pubmed | 6.03e-05 | 37 | 71 | 3 | 24335282 | ||
| Pubmed | 6.03e-05 | 37 | 71 | 3 | 19266077 | ||
| Pubmed | A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition. | 6.03e-05 | 37 | 71 | 3 | 21725307 | |
| Pubmed | 6.05e-05 | 103 | 71 | 4 | 21706016 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 6.13e-05 | 6 | 71 | 2 | 9506531 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 16940996 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 21095589 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 2426947 | ||
| Pubmed | Pleiotropic patterning response to activation of Shh signaling in the limb apical ectodermal ridge. | 6.13e-05 | 6 | 71 | 2 | 21465622 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 6.13e-05 | 6 | 71 | 2 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 6.13e-05 | 6 | 71 | 2 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 6.13e-05 | 6 | 71 | 2 | 6389236 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 10446746 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 6.13e-05 | 6 | 71 | 2 | 10534397 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 16230384 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 10943845 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 21699904 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 6.13e-05 | 6 | 71 | 2 | 9673377 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 6.13e-05 | 6 | 71 | 2 | 19275937 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 15581362 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 6988303 | ||
| Pubmed | 6.43e-05 | 205 | 71 | 5 | 20436479 | ||
| Pubmed | MTG8 interacts with LHX6 to specify cortical interneuron subtype identity. | 7.07e-05 | 39 | 71 | 3 | 36064547 | |
| Pubmed | 7.21e-05 | 210 | 71 | 5 | 16537572 | ||
| Pubmed | Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons. | 7.63e-05 | 40 | 71 | 3 | 27657450 | |
| Pubmed | 7.89e-05 | 1103 | 71 | 10 | 34189442 | ||
| Pubmed | 8.08e-05 | 689 | 71 | 8 | 36543142 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 18981215 | ||
| Pubmed | BRIT1/MCPH1 links chromatin remodelling to DNA damage response. | 8.57e-05 | 7 | 71 | 2 | 19525936 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 11711546 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 14756671 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 8.57e-05 | 7 | 71 | 2 | 8006028 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 10416788 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 1724753 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 28369036 | ||
| Pubmed | Type II and type IX collagen transcript isoforms are expressed during mouse testis development. | 8.57e-05 | 7 | 71 | 2 | 12606408 | |
| Pubmed | Defects and rescue of the minor salivary glands in Eda pathway mutants. | 8.57e-05 | 7 | 71 | 2 | 20969842 | |
| Pubmed | TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner. | 8.57e-05 | 7 | 71 | 2 | 20508149 | |
| Pubmed | Target genes of the largest human SWI/SNF complex subunit control cell growth. | 8.57e-05 | 7 | 71 | 2 | 21118156 | |
| Pubmed | Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter. | 8.57e-05 | 7 | 71 | 2 | 21360626 | |
| Pubmed | 8.97e-05 | 220 | 71 | 5 | 24550385 | ||
| Pubmed | Epithelial inactivation of Yy1 abrogates lung branching morphogenesis. | 9.49e-05 | 43 | 71 | 3 | 26329601 | |
| Pubmed | 1.01e-04 | 916 | 71 | 9 | 32203420 | ||
| Pubmed | CHD7 cooperates with PBAF to control multipotent neural crest formation. | 1.14e-04 | 8 | 71 | 2 | 20130577 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 36335117 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 26986003 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 3997552 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 29422532 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 1377218 | ||
| Interaction | TBXT interactions | 3.10e-06 | 116 | 70 | 6 | int:TBXT | |
| Interaction | C1QTNF1 interactions | 2.13e-05 | 47 | 70 | 4 | int:C1QTNF1 | |
| Interaction | SOX9 interactions | 2.20e-05 | 97 | 70 | 5 | int:SOX9 | |
| Interaction | RBPJ interactions | 2.84e-05 | 254 | 70 | 7 | int:RBPJ | |
| Interaction | SH3RF1 interactions | 3.69e-05 | 108 | 70 | 5 | int:SH3RF1 | |
| Interaction | CRK interactions | 4.19e-05 | 370 | 70 | 8 | int:CRK | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 3.81e-04 | 219 | 71 | 4 | chr7q22 | |
| Cytoband | 7q22.1 | 7.35e-04 | 113 | 71 | 3 | 7q22.1 | |
| GeneFamily | Collagens | 1.49e-07 | 46 | 49 | 5 | 490 | |
| GeneFamily | Sterile alpha motif domain containing | 9.39e-05 | 88 | 49 | 4 | 760 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.24e-03 | 26 | 49 | 2 | 253 | |
| GeneFamily | Ankyrin repeat domain containing | 4.14e-03 | 242 | 49 | 4 | 403 | |
| Coexpression | NABA_COLLAGENS | 1.26e-07 | 44 | 71 | 5 | M3005 | |
| Coexpression | NABA_COLLAGENS | 5.63e-06 | 43 | 71 | 4 | MM17060 | |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 1.69e-05 | 199 | 71 | 6 | M7779 | |
| Coexpression | GU_PDEF_TARGETS_UP | 4.19e-05 | 71 | 71 | 4 | M3955 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 3.57e-07 | 174 | 71 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.38e-07 | 197 | 71 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.38e-07 | 197 | 71 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.75e-06 | 160 | 71 | 5 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 168 | 71 | 5 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 181 | 71 | 5 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 186 | 71 | 5 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 189 | 71 | 5 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.29e-05 | 189 | 71 | 5 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-05 | 192 | 71 | 5 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 71 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 71 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 71 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 196 | 71 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 196 | 71 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 1.58e-05 | 197 | 71 | 5 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.58e-05 | 197 | 71 | 5 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 198 | 71 | 5 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 198 | 71 | 5 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.61e-05 | 198 | 71 | 5 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.61e-05 | 198 | 71 | 5 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.65e-05 | 199 | 71 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.65e-05 | 199 | 71 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.69e-05 | 200 | 71 | 5 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.69e-05 | 200 | 71 | 5 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 200 | 71 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.69e-05 | 200 | 71 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.11e-05 | 112 | 71 | 4 | 153614f307525af56501ac8f9c357c5f7de7882c | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.11e-05 | 112 | 71 | 4 | ba0bd3a77c4865a71fb92d195cd7459c562b63db | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.11e-05 | 112 | 71 | 4 | f9a796b4b5e227096ab360ca9ec08b1c564ac1eb | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.40e-05 | 129 | 71 | 4 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.26e-05 | 134 | 71 | 4 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.20e-05 | 148 | 71 | 4 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 153 | 71 | 4 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 159 | 71 | 4 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.21e-04 | 159 | 71 | 4 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.21e-04 | 159 | 71 | 4 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 61 | 71 | 3 | d0b33a48ee2faf68b270f9279c630437f3e8b20b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-04 | 164 | 71 | 4 | 24fdea5113d92b96f56b06dd2449910a3c785e69 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 165 | 71 | 4 | 9de841c1c95967c562720feba930246debc626fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 165 | 71 | 4 | a612a7d3a5415ecacc3df8fbff0ce498f982aad0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 165 | 71 | 4 | cdc94a640ec01c6892521bcd6f0ee0a66ff23866 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 167 | 71 | 4 | 2ca1b994583edf4e197535ffac8fb0c1142f0dc1 | |
| ToppCell | Severe-Lymphoid-NK-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.47e-04 | 167 | 71 | 4 | 8d41015871616ab7eced5104cd8f70d0efe504f2 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 169 | 71 | 4 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.57e-04 | 170 | 71 | 4 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 1.57e-04 | 170 | 71 | 4 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 171 | 71 | 4 | f16cb64b8844c2668922c786888efaa9f873afcc | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 1.60e-04 | 171 | 71 | 4 | 9ecef653f6916572bf5fbee5aea6c577d04e96ba | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 171 | 71 | 4 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 171 | 71 | 4 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.64e-04 | 172 | 71 | 4 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | primary_auditory_cortex_(A1C)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 172 | 71 | 4 | 20ea9db009370aa6235365ce93e153eb5b28db94 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 173 | 71 | 4 | 9a3500b06d00d1d4ee42910a3a73327b21beab52 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 173 | 71 | 4 | 7186add017271382ecafbff8ee87afb45fbfc745 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 173 | 71 | 4 | 7e2149205e119cec4f5099c83c85d1e13470137a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-04 | 175 | 71 | 4 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 177 | 71 | 4 | b326376e879afef579b1b7094d756aaff0de270b | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 177 | 71 | 4 | 393882f1bf7658a17e10a771b803339f16fb2e69 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.87e-04 | 178 | 71 | 4 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 181 | 71 | 4 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 181 | 71 | 4 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-04 | 181 | 71 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 181 | 71 | 4 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 182 | 71 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 2.04e-04 | 182 | 71 | 4 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | droplet-Lung-nan-21m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | 40539ade8c3cd12b61f1cd0d493828e58282796b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 182 | 71 | 4 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.08e-04 | 183 | 71 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-04 | 183 | 71 | 4 | 0f6799e4f058bed546fe5759502430f4a19635da | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 183 | 71 | 4 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-04 | 183 | 71 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 183 | 71 | 4 | 450c30d2e389fcb17825394c27f9ccc4f33022e3 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-04 | 183 | 71 | 4 | 8746e6ecc6bf9e194cc9cdf9b07da63f0fcf8b5f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-04 | 183 | 71 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK-Cycling_NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.08e-04 | 183 | 71 | 4 | 19652ca16989cb0be7d444cb5bf209b32d163bdb | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-04 | 183 | 71 | 4 | 8ef5223e46f1fd81a856261248cc77e7c7e72ef6 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.12e-04 | 184 | 71 | 4 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-CD8_Tmem|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-04 | 184 | 71 | 4 | 61e2a8b9a42e5788fb4e47c77cc5de65420acbfa | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.12e-04 | 184 | 71 | 4 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 185 | 71 | 4 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 185 | 71 | 4 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.17e-04 | 185 | 71 | 4 | 2d95713deaa05fb3372f4337ef156027e4d8ec8a | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.21e-04 | 186 | 71 | 4 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 186 | 71 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-04 | 186 | 71 | 4 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.26e-04 | 187 | 71 | 4 | 69b47f00598d647e2a99427ebddf42c339428e47 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 187 | 71 | 4 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.26e-04 | 187 | 71 | 4 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 187 | 71 | 4 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.26e-04 | 187 | 71 | 4 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 187 | 71 | 4 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-04 | 187 | 71 | 4 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.26e-04 | 187 | 71 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-04 | 188 | 71 | 4 | f8e6247bedc0ba494c5bb551539cb8ba5a97f557 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.31e-04 | 188 | 71 | 4 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.31e-04 | 188 | 71 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 188 | 71 | 4 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 2.54e-06 | 195 | 71 | 7 | 1163_DN | |
| Drug | AC1L1KMJ | 1.67e-05 | 476 | 71 | 9 | CID000030956 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 2.45e-05 | 185 | 71 | 6 | 6945_UP | |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 2.61e-05 | 187 | 71 | 6 | 5678_UP | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; HL60; HG-U133A | 3.02e-05 | 192 | 71 | 6 | 1419_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.11e-05 | 193 | 71 | 6 | 3262_UP | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 1296_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 3429_DN | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 3144_UP | |
| Drug | idebenone | 3.47e-05 | 59 | 71 | 4 | CID000003686 | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 4948_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 5563_UP | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 4606_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; HL60; HG-U133A | 3.59e-05 | 198 | 71 | 6 | 1438_DN | |
| Drug | Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A | 3.69e-05 | 199 | 71 | 6 | 7319_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.69e-05 | 199 | 71 | 6 | 3280_UP | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | 3.80e-05 | 200 | 71 | 6 | 3432_DN | |
| Drug | AC1LAKND | 4.22e-05 | 62 | 71 | 4 | CID000470146 | |
| Drug | BAPN | 7.20e-05 | 71 | 71 | 4 | CID000001647 | |
| Drug | L-3,4-dehydroproline | 8.03e-05 | 73 | 71 | 4 | CID000094284 | |
| Drug | ethosuximide | 8.47e-05 | 74 | 71 | 4 | CID000003291 | |
| Drug | halofuginone lactate | 1.45e-04 | 85 | 71 | 4 | CID000062891 | |
| Drug | CNS 1145 | 1.48e-04 | 33 | 71 | 3 | CID000190902 | |
| Drug | IHC-64 | 1.48e-04 | 33 | 71 | 3 | CID000162753 | |
| Drug | 4-hydroxyproline | 1.89e-04 | 91 | 71 | 4 | CID000000825 | |
| Drug | GK-101 | 1.93e-04 | 36 | 71 | 3 | CID000161853 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.08e-04 | 173 | 71 | 5 | 1016_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.08e-04 | 173 | 71 | 5 | 4237_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.13e-04 | 174 | 71 | 5 | 1019_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.25e-04 | 176 | 71 | 5 | 1535_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.31e-04 | 177 | 71 | 5 | 6551_DN | |
| Drug | aldosterone | 2.37e-04 | 397 | 71 | 7 | CID000005839 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.37e-04 | 178 | 71 | 5 | 1112_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 2.62e-04 | 182 | 71 | 5 | 5010_UP | |
| Drug | Bepridil | 2.65e-04 | 8 | 71 | 2 | DB01244 | |
| Drug | copper(I) iodide | 2.65e-04 | 8 | 71 | 2 | CID000024350 | |
| Drug | salinomycin | 2.83e-04 | 185 | 71 | 5 | ctd:C010327 | |
| Drug | ticlopidine | 3.04e-04 | 103 | 71 | 4 | CID000005472 | |
| Drug | Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 3.05e-04 | 188 | 71 | 5 | 4386_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 3.12e-04 | 189 | 71 | 5 | 6954_UP | |
| Drug | N-acetyl-L-aspartate | 3.27e-04 | 105 | 71 | 4 | CID000065065 | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 3574_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 3.36e-04 | 192 | 71 | 5 | 4330_DN | |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.36e-04 | 192 | 71 | 5 | 5967_UP | |
| Drug | dodecanal | 3.40e-04 | 9 | 71 | 2 | CID000008194 | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 1644_DN | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 3.44e-04 | 193 | 71 | 5 | 462_DN | |
| Drug | ethylene glycol tetraacetic acid | 3.51e-04 | 44 | 71 | 3 | CID000006207 | |
| Drug | acetazolamide | 3.52e-04 | 107 | 71 | 4 | CID000001986 | |
| Drug | paclitaxel; Down 200; 0.1uM; MCF7; HG-U133A | 3.52e-04 | 194 | 71 | 5 | 640_DN | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 5362_UP | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 3938_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 4319_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 6712_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 4991_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; HL60; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 1274_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 4180_DN | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 4597_DN | |
| Drug | Acemetacin [53164-05-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 2411_UP | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 5676_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 7419_DN | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 3372_UP | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 5011_UP | |
| Drug | D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 6782_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A | 3.69e-04 | 196 | 71 | 5 | 1558_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 1344_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4296_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 3255_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4826_DN | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Up 200; 13uM; HL60; HG-U133A | 3.69e-04 | 196 | 71 | 5 | 1604_UP | |
| Drug | hydroxylysine | 3.77e-04 | 109 | 71 | 4 | CID000001029 | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 4674_UP | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 3504_UP | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 1145_DN | |
| Drug | Famotidine [76824-35-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 1529_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 5507_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 7344_UP | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 4113_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 2259_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 1809_DN | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 4766_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 4730_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 5865_DN | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 3303_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6829_UP | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 4535_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 2514_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6936_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 3930_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; HL60; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 2350_UP | |
| Drug | C75; Up 200; 10uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6423_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 5082_UP | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; HL60; HG-U133A | 3.87e-04 | 198 | 71 | 5 | 1721_DN | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | 3.87e-04 | 198 | 71 | 5 | 5064_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 3.87e-04 | 198 | 71 | 5 | 3621_DN | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.87e-04 | 198 | 71 | 5 | 3259_DN | |
| Drug | DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.87e-04 | 198 | 71 | 5 | 7462_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 3.87e-04 | 198 | 71 | 5 | 6019_DN | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.87e-04 | 198 | 71 | 5 | 5003_UP | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A | 3.87e-04 | 198 | 71 | 5 | 1316_DN | |
| Disease | Childhood Absence Epilepsy | 1.19e-04 | 7 | 71 | 2 | C4281785 | |
| Disease | Epilepsy, Minor | 1.19e-04 | 7 | 71 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 1.19e-04 | 7 | 71 | 2 | C0014553 | |
| Disease | Akinetic Petit Mal | 1.19e-04 | 7 | 71 | 2 | C0001890 | |
| Disease | Epilepsy, Absence, Atypical | 1.19e-04 | 7 | 71 | 2 | C0751124 | |
| Disease | Absence Seizure Disorder | 1.19e-04 | 7 | 71 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 1.19e-04 | 7 | 71 | 2 | C4317339 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.03e-04 | 9 | 71 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | EVL MAP2K4 TRMT2A COL19A1 HOXD11 SPEN CIC CUX1 NOTCH3 ZNF541 | 2.41e-04 | 1074 | 71 | 10 | C0006142 |
| Disease | Global developmental delay | 3.03e-04 | 133 | 71 | 4 | C0557874 | |
| Disease | collagen disease (implicated_via_orthology) | 3.71e-04 | 12 | 71 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Connective Tissue Diseases | 4.38e-04 | 13 | 71 | 2 | C0009782 | |
| Disease | Coffin-Siris syndrome | 4.38e-04 | 13 | 71 | 2 | C0265338 | |
| Disease | platelet component distribution width | 4.55e-04 | 755 | 71 | 8 | EFO_0007984 | |
| Disease | coronary artery disease | COL4A2 MORN1 TENT4A GLS SMARCA4 DUOX2 RPRD2 DCLK2 ZNF831 TNXB | 5.55e-04 | 1194 | 71 | 10 | EFO_0001645 |
| Disease | Tremor, Rubral | 6.70e-04 | 16 | 71 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 6.70e-04 | 16 | 71 | 2 | C0750937 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 6.70e-04 | 16 | 71 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Ataxia, Motor | 6.70e-04 | 16 | 71 | 2 | C0278161 | |
| Disease | Abnormal coordination | 6.70e-04 | 16 | 71 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 6.70e-04 | 16 | 71 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 6.70e-04 | 16 | 71 | 2 | C0240991 | |
| Disease | Feeding difficulties | 8.52e-04 | 18 | 71 | 2 | C0232466 | |
| Disease | kidney volume | 8.52e-04 | 18 | 71 | 2 | EFO_0600044 | |
| Disease | Cleft Palate | 9.96e-04 | 81 | 71 | 3 | C0008925 | |
| Disease | Sarcoma | 1.16e-03 | 21 | 71 | 2 | C1261473 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 1.16e-03 | 21 | 71 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.27e-03 | 195 | 71 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.29e-03 | 335 | 71 | 5 | EFO_0009931 | |
| Disease | myocardial infarction | 1.57e-03 | 350 | 71 | 5 | EFO_0000612 | |
| Disease | Ataxia | 1.65e-03 | 25 | 71 | 2 | C0004134 | |
| Disease | neurotic disorder | 1.88e-03 | 101 | 71 | 3 | EFO_0004257 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 2.01e-03 | 221 | 71 | 4 | C0011860 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.07e-03 | 28 | 71 | 2 | DOID:4194 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PASGPHVSEGPPGPR | 2391 | O00555 | |
| SSRGAPPGPAPGHPQ | 351 | Q6UXG8 | |
| HGTPGPSITGVPGPA | 1186 | Q14031 | |
| PGPPGHPGVLPEGAT | 156 | Q14050 | |
| GPHPGPGTRRPTSGP | 26 | Q9NY47 | |
| PLTPAGHTGGPEPRP | 336 | Q9NW68 | |
| VPSAPTGPLGPPGHG | 471 | P46379 | |
| ATTAGPAPGGPAQPP | 581 | P46379 | |
| PPSLGDPGEPAAHPG | 1436 | O14514 | |
| DPGEPAAHPGPSTGP | 1441 | O14514 | |
| HEGGPVEGPGPLPSP | 1391 | P39880 | |
| GPNGGKQHPPPTTPI | 246 | P54259 | |
| PGSDIHGDPGFPGPP | 1211 | P08572 | |
| DVPGPPGPPSHGLST | 381 | O00189 | |
| EGSHPQPLGGPEPGP | 206 | P46108 | |
| PGPVGSPAPGHPAVS | 21 | P45985 | |
| HPAAGEVPPGPGGPS | 301 | P78411 | |
| EVPPGPGGPSVIHSP | 306 | P78411 | |
| GSTHPQPGVSPPAAP | 86 | O94925 | |
| PAHVPAPSPQGPGGL | 726 | P33897 | |
| HPRGTPPTAQEPPGG | 401 | Q5T089 | |
| GGPVSFPPAPGPHFG | 306 | Q06416 | |
| GAGPCAPGHPDAAPP | 771 | Q9H252 | |
| PHPPPAAPGGERAGT | 746 | Q8N568 | |
| PGERSHPQGLGPPAP | 971 | Q9NRD8 | |
| SGRGPAPAIPSPGPH | 791 | Q9UQ16 | |
| PPGSPGPHAPQLGSL | 341 | Q6ZS72 | |
| PPPPLPAGGAQGSSH | 201 | Q9UI08 | |
| QPSGPRSPPGPHGLG | 2026 | Q9UM47 | |
| GAAHPTGTPFGPPPH | 716 | Q8WXX7 | |
| AAPAGGAPPAHAPGP | 31 | Q14657 | |
| GVGPAPAPHSLPEPG | 171 | P41161 | |
| AAGGDAGHAPFPPPP | 131 | Q8N319 | |
| HPGPRGPAPAGSPSQ | 146 | Q5XG87 | |
| MASPPRHGPPGPASG | 1 | Q9Y4H2 | |
| PPGEQPPSGSGHGRP | 171 | Q9H461 | |
| HQGPPGSPGIPGIPA | 996 | Q14993 | |
| PVCAAPGPPHGPAGA | 146 | P31277 | |
| LSQHGSPGIPGPPGP | 821 | Q96P44 | |
| GPSSAPPVPPKDHGG | 1211 | Q5VT52 | |
| PPPGSLCSEPHQGPG | 486 | P55291 | |
| QAPHPVPGGGSLPPR | 726 | Q9UF33 | |
| APAFHTGGPPGPVDP | 36 | Q10571 | |
| HVGGPPPSPASPSIQ | 436 | Q16799 | |
| GHPPVSPSAPAPAGT | 16 | Q8NBV8 | |
| GVLGPHSPPAQPTPG | 596 | Q8IZ69 | |
| SHPGPASGPGPDTGP | 191 | Q99932 | |
| SPPLGTHNPGGLKPP | 61 | P78426 | |
| SVTVAVHPPPVPGPG | 1376 | Q13635 | |
| SPGPPSAGHPIPTQG | 46 | P51532 | |
| GGAEARGPPPPKAHP | 1081 | O15357 | |
| PPPSHVPAGGPGLED | 106 | Q6P9B9 | |
| PLTLGPTPGQSPGPH | 1456 | A1L4H1 | |
| PTPGQSPGPHGPCVA | 1461 | A1L4H1 | |
| PIPPTGAAGPPAVHG | 971 | Q8TAQ2 | |
| GVHPPTSGVHPPAPG | 321 | Q15428 | |
| TSGVHPPAPGVHPPA | 326 | Q15428 | |
| GVHPQPPGVHPSAPG | 406 | Q15428 | |
| QGASAAPGDPHPPGP | 1636 | Q9Y566 | |
| PSHGGSPVGPPQLPI | 921 | P55201 | |
| APHPMDGPPGGSTPV | 311 | Q96P48 | |
| PGPGPPHPLGVVESG | 106 | Q96RK0 | |
| GTPGPPPAHGAALQP | 26 | Q15654 | |
| PGSPGHQAPRPGPSV | 681 | Q8IU68 | |
| GVPSEGPAHIPPGSP | 276 | Q9H171 | |
| GPAHIPPGSPPVSAT | 281 | Q9H171 | |
| SPPVASGGIPHQSPP | 2481 | Q96T58 | |
| PHLASGSPPPGLPSG | 301 | Q9C0H9 | |
| GPAGSAPGLPPPQHG | 316 | Q6NSZ9 | |
| APRPPPQPGGHTVGA | 36 | P22105 | |
| SSPHNRGSPPVPGGP | 196 | O43516 | |
| GPPCPSPVGGGDPLH | 161 | Q13563 | |
| TVPKPGPQPGPHGSL | 701 | A8K0R7 | |
| PGPTGAAPVSAPAPG | 26 | Q9NRL3 | |
| PGPPGAPGGQASPHL | 21 | Q5JPB2 | |
| APGPHLPPRGSVPGD | 86 | Q7Z7E8 | |
| PPPSTAGEPGPAGCH | 956 | Q9H0D2 | |
| AAAPGPAGAASPHPP | 231 | Q5SQQ9 | |
| GPAAPSPGSAPVPGT | 26 | Q96HR8 |